Exploring pta Alternatives in the Development of Ruthenium–Arene Anticancer Compounds

Organoruthenium pyrithione (1-hydroxypyridine-2-thione) complexes have been shown in our recent studies to be a promising family of compounds for development of new anticancer drugs. The complex [(η(6)-p-cymene)Ru(pyrithionato)(pta)]PF(6) contains phosphine ligand pta (1,3,5-triaza-7-phosphaadamanta...

Descripción completa

Detalles Bibliográficos
Autores principales: Kljun, Jakob, Rebernik, Mihaela, Balsa, Lucía M., Kladnik, Jerneja, Rapuš, Uroš, Trobec, Tomaž, Sepčić, Kristina, Frangež, Robert, León, Ignacio E., Turel, Iztok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058425/
https://www.ncbi.nlm.nih.gov/pubmed/36985471
http://dx.doi.org/10.3390/molecules28062499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058425/
https://www.ncbi.nlm.nih.gov/pubmed/36985471
http://dx.doi.org/10.3390/molecules28062499

Ejemplares similares